Perioperative Management of Comorbidities Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Perioperative Management of Comorbidities. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Perioperative Management of Comorbidities Indian Medical PG Question 1: A 63-year-old man presents for an elective laparoscopic cholecystectomy. He is obese, has angina at rest, and chronic obstructive pulmonary disease (COPD). Which of the following would be his American society of Anesthesiologists (ASA) physical status classification
- A. ASA II
- B. ASA I
- C. ASA IV
- D. ASA III (Correct Answer)
Perioperative Management of Comorbidities Explanation: ***ASA III***
- This patient has **severe systemic disease** (angina at rest, COPD, obesity) that limits activity but is not incapacitating, aligning with the criteria for **ASA III**.
- **Angina at rest** and **chronic obstructive pulmonary disease (COPD)** are significant comorbidities that place the patient in this category.
*ASA II*
- **ASA II** is defined by **mild systemic disease** that does not limit activity.
- The patient's conditions such as **angina at rest** and **COPD** are more severe than what would be considered mild.
*ASA I*
- **ASA I** is reserved for a **normal, healthy patient** with no systemic disease.
- This patient has multiple significant systemic diseases, unequivocally ruling out ASA I.
*ASA IV*
- **ASA IV** describes a patient with **severe systemic disease** that is a constant threat to life.
- While critical, the patient's conditions (angina at rest, COPD) are stabilised enough for an **elective procedure** and are not an immediate, constant threat to life.
Perioperative Management of Comorbidities Indian Medical PG Question 2: After laparoscopic cholecystectomy what should be the urine output of the patient if the renal function of the patient is normal?
- A. 0.5 ml/min
- B. 0.1 CC/hr
- C. 1 ml/kg/hr
- D. 0.5-1 ml/kg/hr (Correct Answer)
Perioperative Management of Comorbidities Explanation: ***0.5-1 ml/kg/hr***
- The standard acceptable urine output for a postoperative patient with normal renal function is **0.5-1 ml/kg/hr** (some sources extend this to 0.5-1.5 ml/kg/hr).
- A minimum of **0.5 ml/kg/hr** is considered adequate renal perfusion and function, while outputs up to 1-1.5 ml/kg/hr indicate excellent hydration and renal function.
- This weight-adjusted measure is the gold standard for assessing postoperative urine output and renal function.
*0.5 ml/min*
- This is an absolute rate (not weight-adjusted) and is inadequate as a general measure.
- For a 70 kg patient, this would be only 0.43 ml/kg/hr, which is below the minimum acceptable threshold.
*0.1 CC/hr*
- This rate is **severely low** and indicates **oliguria** or **anuria**.
- This suggests **acute kidney injury**, severe dehydration, or inadequate renal perfusion requiring immediate intervention.
*1 ml/kg/hr*
- While this value falls within the acceptable range, it represents only a single point rather than the **standard range of 0.5-1 ml/kg/hr**.
- The range option is more comprehensive and represents the full spectrum of normal postoperative urine output.
Perioperative Management of Comorbidities Indian Medical PG Question 3: What is the correct sequence of medication administration for pre-operative prophylaxis in pheochromocytoma?
- A. Beta blockade followed by alpha blockade
- B. Simultaneous alpha and beta blockade
- C. Alpha blockade followed by beta blockade (Correct Answer)
- D. Alpha blockade only
Perioperative Management of Comorbidities Explanation: ***Alpha blockade followed by beta blockade***
- **Alpha blockade** should always be initiated first to control **hypertension** and prevent a **hypertensive crisis** during surgery. This is critical because pheochromocytoma causes excessive catecholamine release, leading to profound vasoconstriction.
- **Beta blockade** is then added only after adequate alpha blockade has been achieved to control **tachycardia** and arrhythmias, preventing **unopposed alpha-adrenergic stimulation** which could paradoxically worsen hypertension.
*Simultaneous alpha and beta blockade*
- Administering both simultaneously is dangerous because **beta blockade** can mask the effects of inadequate alpha blockade.
- This can lead to **unopposed alpha-adrenergic stimulation** after beta blockade, causing severe **vasoconstriction** and hypertensive crisis.
*Beta blockade followed by alpha blockade*
- Initiating with **beta blockade** without prior **alpha blockade** is absolutely contraindicated in pheochromocytoma.
- This can lead to severe and potentially fatal **hypertension** due to **unopposed alpha-adrenergic stimulation** as beta blockade prevents vasodilation.
*Alpha blockade only*
- While essential for initial management, **alpha blockade alone** might not fully control all symptoms, especially **tachycardia** and **arrhythmias** caused by high circulating catecholamine levels.
- Adding a **beta blocker** after achieving adequate alpha blockade helps in controlling these cardiac effects, optimizing patient preparation for surgery.
Perioperative Management of Comorbidities Indian Medical PG Question 4: Management of RCC less than 4 cm in size:
- A. Surgery followed by chemotherapy
- B. Partial nephrectomy (Correct Answer)
- C. Radical nephrectomy
- D. Chemotherapy
Perioperative Management of Comorbidities Explanation: ***Correct: Partial nephrectomy***
- For **renal cell carcinoma (RCC) less than 4 cm (T1a)**, partial nephrectomy is the **gold standard** as it offers equivalent oncological outcomes to radical nephrectomy while preserving renal function.
- This approach minimizes the risk of **chronic kidney disease** and its associated complications without compromising cancer control for appropriately selected smaller tumors.
- **Nephron-sparing surgery** is now the preferred approach per EAU and AUA guidelines for small renal masses.
*Incorrect: Surgery followed by chemotherapy*
- While surgery is the primary treatment, **adjuvant chemotherapy** is generally **not effective** for localized RCC and is not routinely recommended for small tumors.
- Systemic therapies are typically reserved for **advanced or metastatic RCC**, or in specific clinical trials.
*Incorrect: Radical nephrectomy*
- This involves removing the entire kidney, which is typically reserved for **larger tumors (T1b and above)**, centrally located tumors, or those with significant renal parenchymal involvement.
- For tumors under 4 cm, radical nephrectomy leads to **unnecessary loss of renal function** compared to partial nephrectomy.
*Incorrect: Chemotherapy*
- **RCC is notoriously chemoresistant**, meaning traditional chemotherapy drugs have very limited efficacy in treating this cancer.
- Chemotherapy alone is **not a primary treatment modality** for localized RCC due to its poor response rates in this cancer type.
Perioperative Management of Comorbidities Indian Medical PG Question 5: A 32-year-old female patient with Graves' disease with eye signs and enlarged thyroid planned for a total thyroidectomy. What can be given in the preoperative period to reduce intraoperative bleeding in the patient?
- A. Propylthiouracil
- B. Potassium iodide (Correct Answer)
- C. Betamethasone
- D. Propranolol
Perioperative Management of Comorbidities Explanation: ***Potassium iodide***
- **Potassium iodide** (e.g., Lugol's solution) is given preoperatively to patients with Graves' disease undergoing thyroidectomy because it **decreases the vascularity** of the thyroid gland, thereby reducing intraoperative bleeding.
- It also helps to **block the release of thyroid hormones** from the thyroid gland, stabilizing the patient's thyroid function.
*Propylthiouracil*
- **Propylthiouracil (PTU)** is an **antithyroid drug** that prevents the synthesis of thyroid hormones by inhibiting the organification of iodine and the coupling of iodotyrosines.
- Although it helps to achieve a **euthyroid state** before surgery, it does not directly reduce the vascularity of the thyroid gland to decrease intraoperative bleeding.
*Betamethasone*
- **Betamethasone** is a corticosteroid used for its **anti-inflammatory** and immunosuppressive effects.
- It is not typically used preoperatively in Graves' disease to reduce thyroid vascularity or bleeding; its primary role might be in managing severe **ophthalmopathy** or thyroid storm, not surgical bleeding.
*Propranolol*
- **Propranolol** is a **beta-blocker** used to control the adrenergic symptoms of hyperthyroidism, such as **tachycardia**, palpitations, and tremors.
- While it helps to achieve a more stable cardiac state for surgery, it does not directly impact the **vascularity** of the thyroid gland or reduce surgical bleeding.
Perioperative Management of Comorbidities Indian Medical PG Question 6: Which of the following is not a component of the Goldman Revised Cardiac Risk Index?
- A. History of preoperative treatment with insulin
- B. History of preoperative serum creatinine >2.0 mg/dL
- C. Age > 80 yrs (Correct Answer)
- D. History of ischemic heart disease
Perioperative Management of Comorbidities Explanation: ***Age > 80 yrs***
- **Age** is not a parameter included in the Goldman Revised Cardiac Risk Index for predicting postoperative cardiac complications.
- The index focuses on specific medical conditions and surgical risk factors.
*History of preoperative treatment with insulin*
- This is a component of the **Goldman Revised Cardiac Risk Index**, indicating **insulin-dependent diabetes mellitus**.
- Diabetes requiring insulin treatment is a significant risk factor for cardiac complications during surgery.
*History of preoperative serum creatinine >2.0 mg/dL*
- An elevated **serum creatinine** (>2.0 mg/dL) is a recognized component of the index, reflecting **renal insufficiency**.
- **Renal impairment** is associated with increased cardiac risk in the perioperative period.
*History of ischemic heart disease*
- This is a key component of the Goldman Revised Cardiac Risk Index, as a history of **ischemic heart disease** (e.g., prior myocardial infarction, angina) significantly increases perioperative cardiac risk.
- Patients with existing heart disease are more susceptible to cardiac events during and after surgery.
Perioperative Management of Comorbidities Indian Medical PG Question 7: Which of the following is not a risk factor for postoperative pulmonary complication?
- A. Normal BMI (18.5-24.9) (Correct Answer)
- B. Age 25-40 years
- C. Upper abdominal surgery
- D. Patient with 20 pack years of smoking
Perioperative Management of Comorbidities Explanation: ***Patient with 20 pack years of smoking***
- This is a significant risk factor for postoperative pulmonary complications, as **chronic smoking** impairs lung function and mucociliary clearance.
- Patients with a history of **20 pack-years or more** are at a substantially increased risk of developing atelectasis, pneumonia, and respiratory failure after surgery.
*Normal BMI (18.5-24.9)*
- A **normal BMI** is not considered a risk factor for postoperative pulmonary complications; instead, it is associated with a lower risk compared to obesity or underweight states.
- Patients with a normal BMI generally have **better respiratory mechanics** and lung volumes, reducing their susceptibility to pulmonary issues.
*Age 25-40 years*
- This age range is generally associated with a **lower risk** of postoperative pulmonary complications compared to very young or elderly patients.
- Younger adults typically have **better physiological reserves** and healthier lungs, contributing to a reduced incidence of respiratory problems post-surgery.
*Upper abdominal surgery*
- **Upper abdominal surgery** is a significant risk factor for postoperative pulmonary complications due to its proximity to the diaphragm.
- It often leads to **diaphragmatic dysfunction**, reduced lung volumes, and increased pain, all of which predispose patients to atelectasis and pneumonia.
Perioperative Management of Comorbidities Indian Medical PG Question 8: A patient on long-term high-dose steroid therapy (prednisolone 20 mg/day for 6 months) is scheduled for major abdominal surgery. What is the most essential perioperative requirement?
- A. Insulin only
- B. Hydrocortisone only (Correct Answer)
- C. Both
- D. None of the options
Perioperative Management of Comorbidities Explanation: ***Hydrocortisone only***
- Patients on chronic **high-dose steroid therapy** (>5 mg prednisolone daily for >3 weeks) are at risk of **adrenal insufficiency** during surgical stress due to suppression of the hypothalamic-pituitary-adrenal (HPA) axis.
- **Hydrocortisone stress dose** (100 mg IV at induction, followed by 50 mg every 8 hours) is the **most essential and immediate requirement** to prevent **adrenal crisis** during major surgery.
- Hydrocortisone has both glucocorticoid and mineralocorticoid activity, mimicking the body's natural cortisol response to surgical stress.
*Insulin only*
- While steroids can cause **hyperglycemia** requiring insulin management, this is a **secondary concern** compared to preventing life-threatening **adrenal crisis**.
- Insulin addresses a metabolic complication but does not protect against **inadequate cortisol response** to surgical stress.
- **Without stress-dose steroids**, the patient risks hemodynamic collapse regardless of glucose control.
*Both*
- Although **both** medications might eventually be needed if hyperglycemia develops, the question asks for the **most essential** requirement.
- **Hydrocortisone is non-negotiable** and must be given prophylactically; insulin is only needed if blood glucose is elevated.
- Prioritizing both equally misses the critical time-sensitive need for **adrenal axis support**.
*None of the options*
- This is incorrect because patients on chronic high-dose steroids undergoing major surgery **absolutely require stress-dose steroid coverage**.
- Failure to administer hydrocortisone can result in **acute adrenal crisis** with severe hypotension, shock, and potential mortality.
- Modern guidelines confirm the need for perioperative steroid supplementation in high-risk patients.
Perioperative Management of Comorbidities Indian Medical PG Question 9: Patient shows ST depression, troponin rise 6h post-surgery. Next best step is:
- A. 12-lead ECG
- B. Echocardiogram
- C. Cardiology consult (Correct Answer)
- D. Start heparin
Perioperative Management of Comorbidities Explanation: ***Cardiology consult***
- A cardiology consult is the most appropriate next step given the presence of **ST depression** and a **troponin rise** post-surgery, indicating a likely myocardial infarction (MI).
- This allows for prompt comprehensive evaluation, risk stratification, and initiation of specialized cardiac management by an expert.
*12-lead ECG*
- While a 12-lead ECG is an important diagnostic tool, the patient's existing **ST depression** suggests it has already been performed or noted.
- A repeat ECG might be useful for tracking changes, but it doesn't replace the need for expert cardiac evaluation and management.
*Echocardiogram*
- An echocardiogram can assess **cardiac function**, wall motion abnormalities, and valvular issues, which are relevant in MI.
- However, it's a diagnostic test that should be ordered and interpreted in the context of a broader cardiac workup, which a cardiologist can best coordinate.
*Start heparin*
- **Heparin** is an anticoagulant that may be part of the management for an MI, especially in certain types or for prevention of clot extension.
- However, initiating anticoagulation should be done after a thorough assessment of the patient's cardiac status, bleeding risk post-surgery, and in consultation with cardiology, rather than as the immediate next best step.
Perioperative Management of Comorbidities Indian Medical PG Question 10: Preoperative investigations done prior to surgery depend upon which of the following?
1. Type of surgery
2. Patient origin
3. Patient comorbidities
4. Experience of surgeon
- A. 4. Experience of surgeon
- B. 1. Type of surgery (Correct Answer)
- C. 2. Patient origin
- D. 3. Patient comorbidities
Perioperative Management of Comorbidities Explanation: ***1. Type of surgery***
- The **type of surgery** is a primary determinant of preoperative investigations, as it defines the baseline assessment needed based on the procedure's complexity, invasiveness, and physiological stress.
- Minor surgeries (e.g., superficial excisions) typically require minimal investigations, while major surgeries (e.g., cardiac, neurosurgery) mandate comprehensive cardiovascular, pulmonary, and hematological workups.
- **Clinical Note:** In practice, preoperative investigations depend on BOTH the surgery type AND patient comorbidities working together, but this question likely seeks the most fundamental starting point.
*3. Patient comorbidities*
- **Patient comorbidities** are undeniably crucial in determining the extent and nature of preoperative investigations.
- A patient with diabetes, hypertension, or cardiac disease requires additional specific investigations regardless of the surgery type.
- However, the surgery type establishes the baseline framework, which is then modified based on comorbidities.
*2. Patient origin*
- **Patient origin** (geographical location, ethnicity) is generally not a direct determinant of preoperative investigation protocols.
- While certain populations may have higher prevalence of specific conditions, investigations are based on individual patient assessment, not origin.
*4. Experience of surgeon*
- The **experience of the surgeon** does not alter the medical necessity or standard protocols for preoperative investigations.
- Patient safety standards and investigation requirements remain consistent regardless of surgical expertise level.
More Perioperative Management of Comorbidities Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
